Triptans in pregnancy.
作者： Offie P Soldin , Julia Dahlin , Daniel M OʼMara
DOI: 10.1097/FTD.0B013E318162C89B
关键词:
摘要: The triptans are a class of tryptamine-based drugs indicated for in the treatment migraine headaches. act as serotonin (5-hydroxytriptamine) (5-HT) agonists by binding to various receptors, causing vasoconstriction and neuronal inhibition alleviate migraines. There 7 types currently available on U.S. market: almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan zolmitriptan. objective this study was examine use effects pregnancy. Although three have pregnancy registries maintained manufacturer, triptan has not been extensively studied. Information during is relatively more abundant, because it market longer than other may also higher percentage share. no data suggest teratogenicity any triptans, although preterm birth rates appear be elevated.
sci-hub.se 参考文章(37)
D Nelson, 5-HT5 Receptors Current Drug Targets - Cns & Neurological Disorders. ,vol. 3, pp. 53- 58 ,(2004) , 10.2174/1568007043482606
Volker Pfaffenrath, Mathias Rehm, Migraine in pregnancy: what are the safest treatment options? Drug Safety. ,vol. 19, pp. 383- 388 ,(1998) , 10.2165/00002018-199819050-00005
Giuseppe Nappi, Giorgio Sandrini, Grazia Sances, Tolerability of the triptans: clinical implications. Drug Safety. ,vol. 26, pp. 93- 107 ,(2003) , 10.2165/00002018-200326020-00003
David E Johnson, Hans Rollema, Anne W Schmidt, Aileen D McHarg, Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain European Journal of Pharmacology. ,vol. 425, pp. 203- 210 ,(2001) , 10.1016/S0014-2999(01)01151-7
A J Sands, F A Casey, B G Craig, J C Dornan, J Rogers, H C Mulholland, Incidence and risk factors for ventricular septal defect in “low risk” neonates Archives of Disease in Childhood-fetal and Neonatal Edition. ,vol. 81, ,(1999) , 10.1136/FN.81.1.F61
D THOMAS, 5-ht5A receptors as a therapeutic target. Pharmacology & Therapeutics. ,vol. 111, pp. 707- 714 ,(2006) , 10.1016/J.PHARMTHERA.2005.12.006
Karen L. Hoskin, Holger Kaube, Peter J. Goadsby, Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. ,vol. 119, pp. 1419- 1428 ,(1996) , 10.1093/BRAIN/119.5.1419
S O'Quinn, RL Davis, DL Gutterman, GD Pait, AW Fox, Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia. ,vol. 19, pp. 223- 231 ,(1999) , 10.1046/J.1468-2982.1999.019004223.X
Zhiping Zhang, Kevin Chen, Jean C. Shih, Christina T. Teng, Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Molecular Endocrinology. ,vol. 20, pp. 1547- 1561 ,(2006) , 10.1210/ME.2005-0252
L.-O. WAHLUND, J. SÄÄF, E. ENEROTH-GRIMFORS, B. A. NILSSON, S. BEVEGÅRD, Reduced platelet MAO activity during pregnancy Acta Physiologica Scandinavica. ,vol. 126, pp. 135- 138 ,(1986) , 10.1111/J.1748-1716.1986.TB07796.X